The Most Favored Nation Model and Interim Final Rule – What is this?
The rising costs of physician-administered drugs covered under Medicare Part B is one of the largest drivers of Medicare spend which have risen approximately 11.5% annually since 2015, with a total spend of approximately $30 billion in 20191. Lowering drug cost is essential to maintain Medicare for our aging population. Lowering drug prices has been […]
The Most Favored Nation Model and Interim Final Rule – What is this? Read More »
